Pfizer Leucovorin Injection (Calcium Levofolinate)
Calcium Folinate 10.8mg
Prescription medication
Korea Pfizer Pharmaceuticals Co., Ltd.
MFDS item code 199907236 · Notified 1999.11.15 · Insurance code 648903001,648903002,648903003
Reduction of toxicity from folate metabolism antagonists and treatment effect for metastatic colorectal cancer
This drug helps reduce toxicity caused by folate metabolism antagonists and is used to enhance treatment effect when used with 5-Fluorouracil (5-FU) in patients with metastatic colorectal cancer.
1. Methotrexate standard therapy: Administer 6-12mg of Leucovorin intramuscularly every 6 hours, four times a day. 2. Methotrexate-Leucovorin rescue therapy: Administer 15mg intravenously every 3 hours for 9 doses and then 8 doses every 6 hours intravenously or intramuscularly. 3. Combined administration with 5-Fluorouracil (5-FU) for metastatic colorectal cancer: Administer calcium levofolinate 200mg/m² per day at minimum.
This drug is not suitable for the treatment of pernicious anemia or other megaloblastic anemias due to vitamin B12 deficiency. Even when neurological symptoms persist, caution is required as blood conditions may improve. Glass particles from the injection vial may be introduced, so the vial should be carefully handled when injecting, especially when used in children or the elderly. Women who are pregnant or breastfeeding should take special precautions, and in some cases, administration should be avoided. This drug should be used according to a doctor's instructions when used in combination with anticancer agents like methotrexate, requiring blood concentration tests to manage therapeutic effects and side effects. Regular blood tests and liver function tests should be conducted to early detect and manage adverse reactions. This drug may cause allergic reactions or injection site pain, fever, and central nervous system symptoms, so if unusual symptoms occur, consult healthcare professionals immediately. Additionally, it may interact with other medications, so it's important to inform if any other drugs are being taken. Elderly patients may have reduced physiological function, requiring more caution during administration. This drug is contraindicated for intrathecal administration, and intravenous injections should be administered slowly while monitoring calcium content. Store out of reach of children and keep it in the original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to avoid exposure to air and light. Additionally, it is important to store it in a cool place between 2°C and 8°C to maintain its effectiveness.
A transparent yellow injection solution filled in a colorless transparent vial
50mg/5mL x 1 vial, 100mg/10mL x 1 vial, 300mg/30mL x 1 vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Calcium Folinate 10.8mg
Prescription medication
Korea Pfizer Pharmaceuticals Co., Ltd.
Calcium Folinate 3.2mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 16mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.

Calcium Folinate 5.4mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 106.7mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 32mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 53.4mg
Prescription medication
Samjin Pharmaceutical Co., Ltd.
Calcium Folinate 16.2mg
Prescription medication
Korea Pfizer Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.